// App-Quantinova.ai

: Risk for Major and Fatal Bleeding After Discontinuing Oral Anticoagulation for Unprovoked Venous Thromboembolism: Systematic Review and Meta‐analysis

Researchers

Presenter

  • F. Khan

Principal Investigators

  • M. Carrier

  • C. Kearon

  • J. Weitz

  • S. Schulman

  • F. Couturaud

  • C. Becattini

  • G. Agnelli

  • T. Brighton

  • A. Lensing

  • M. Prins

  • S. Parpia

  • B. Hutton

  • G. Andreozzi

  • M. Cushman

  • G. Palareti

  • P. Prandoni

  • H. Buller

  • M. Rodger

Medical Centers

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Montreal University, Montreal, QC, Canada

  • McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada

  • Brest University, Brest, France

  • University of Perugia, Terni, Perugia, Italy

  • Prince of Wales Hospital, Sydney, Australia

  • Bayer AG, Leverkusen, Germany

  • University Hospital Maastricht, Maastricht, Netherlands

  • University Hospital of Parma, Parma, Italy

  • University of Vermont, Burlington, Vermont, United States

  • Arianna Foundation on Anticoagulation, Bologna, Italy

  • Academic Medical Center, Amsterdam, Netherlands

Locations

  • Canada

  • France

  • Italy

  • Australia

  • Germany

  • Netherlands

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved